Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

noumed pharmaceuticals pty ltd - promethazine hydrochloride, quantity: 25 mg - tablet, film coated - excipient ingredients: povidone; magnesium stearate; purified water; maize starch; lactose monohydrate; titanium dioxide; hypromellose; macrogol 6000; indigo carmine aluminium lake - allergies: treatment of allergic conditions including some allergic reactions to drugs, urticaria, contact dermatitis, and allergic reactions to insect bites and stings. ,upper respiratory tract: relief of excessive secretion in the upper respiratory tract as a result of hayfever and allergic rhinitis. ,nausea and vomiting: antiemetic in vomiting of various causes, including post-operative vomiting, irradiation sickness, drug induced nausea, and motion sickness. ,sedation: for short term use on the advice of a doctor or pharmacist.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - somatropin -

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - milrinone 1.43 mg/ml (as lactate. equivalent to 1mg/ml milrinone) - solution for injection - 1 mg/ml - active: milrinone 1.43 mg/ml (as lactate. equivalent to 1mg/ml milrinone) excipient: glucose monohydrate lactic acid sodium hydroxide water for injection - primacor injection is indicated for the short term intravenous therapy of severe congestive heart failure. the majority of experience with intravenous primacor has been in patients receiving digoxin and diuretics. primacor is also indicated for low output states following cardiac surgery, including weaning from cardio-pulmonary bypass pump.

Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

ferring pharmaceuticals private limited - somatropin - injection, powder, for solution - 4 mg - somatropin 4 mg

Ευρωπαϊκή Ένωση - Αγγλικά - EMA (European Medicines Agency)

pharmaswiss ceska republika s.r.o - pegaptanib - wet macular degeneration - ophthalmologicals - macugen is indicated for the treatment of neovascular (wet) age-related macular degeneration (amd).

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

bausch health us, llc - pegaptanib sodium (unii: 3hp012q0fh) (pegaptanib - unii:2h1pa8h1en) - pegaptanib sodium 3.47 mg in 1 ml - macugen® (pegaptanib sodium injection) is indicated for the treatment of neovascular (wet) age-related macular degeneration. macugen is contraindicated in patients with ocular or periocular infections. macugen is contraindicated in patients with known hypersensitivity to pegaptanib sodium or any other excipient in this product. teratogenic effects: pregnancy category b. pegaptanib produced no maternal toxicity and no evidence of teratogenicity or fetal mortality in mice at intravenous doses of up to 40 mg/kg/day (about 7,000 times the recommended human monocular ophthalmic dose of 0.3 mg/eye). pegaptanib crosses the placenta in mice. there are, however, no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. it is not known whether pegaptanib is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when macugen is adm

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

ferring pharmaceuticals ltd - somatropin (rbe) - powder and solvent for solution for injection - 10mg

Ισραήλ - Αγγλικά - Ministry of Health

megapharm ltd - macimorelin as acetate - granules for suspension - macimorelin as acetate 60 mg - macimorelin - this medicinal product is for diagnostic use only.macimorelin aeterna zentaris is indicated for the diagnosis of growth hormone deficiency (ghd) in adults.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

hope pharmaceuticals pty ltd - sodium thiosulfate pentahydrate, quantity: 12.5 g - solution - excipient ingredients: water for injections; potassium chloride; boric acid; sodium hydroxide - hope pharmaceuticals sodium thiosulfate injection is indicated as an antidote in the treatment of cyanide poisoning. it is frequently used in conjunction with sodium nitrite.,sodium thiosulfate is also indicated to prevent sodium nitroprusside induced cyanide poisoning.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

noumed pharmaceuticals pty ltd - pseudoephedrine hydrochloride, quantity: 60 mg - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; calcium hydrogen phosphate dihydrate - fast, temporary relief from a runny nose and reduce the swollen membranes of the nose and sinuses and helping breathe easier.